SonoClear System
Glioma (Brain Tumor) Resection Surgery
Key Facts
About Sonoclear
SonoClear is a private, clinical-stage medical device company developing a novel ultrasound couplant to address a critical unmet need in neurosurgery. Its core product, the SonoClear System, is designed to eliminate imaging artifacts common when using saline, thereby improving diagnostic accuracy and potentially enabling more complete tumor resections with fewer complications. The company is rooted in Norway's leading ultrasound research cluster, has completed Phase 1 of a pivotal multi-center trial, and is led by a management team with commercial and healthcare expertise. SonoClear operates in the high-value intersection of oncology and surgical guidance, targeting a clear improvement in a standard-of-care procedural step.
View full company profile